Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
203,364
Value
$11.6M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026203,364$11.6M<0.1%+80,526+65.6%AddedHolders
Q1 2026122,838$6.94M<0.1%−165,709−57.4%ReducedHolders
Q4 2025288,547$17.1M<0.1%−566,041−66.2%ReducedHolders
Q3 2025854,588$46.3M<0.1%+403,508+89.5%AddedHolders
Q2 2025451,080$24.8M<0.1%+177,265+64.7%AddedHolders
Q1 2025273,815$19.4M<0.1%−55,051−16.7%ReducedHolders
Q4 2024328,866$21.6M<0.1%+41,275+14.4%AddedHolders
Q3 2024287,591$20.2M<0.1%−830,789−74.3%ReducedHolders
Q2 20241,118,380$92.1M<0.1%−4,136,140−78.7%ReducedHolders
Q1 20245,254,520$458.9M0.2%−34,373−0.6%ReducedHolders
Q4 20235,288,893$510.0M0.3%−284,264−5.1%ReducedHolders
Q3 20235,573,157$493.1M0.3%+2,911,886+109.4%AddedHolders
Q2 20232,661,271$230.7M0.1%+1,056,445+65.8%AddedHolders
Q1 20231,604,826$156.1M0.2%−377,663−19.0%ReducedHolders
Q4 20221,982,489$205.2M0.2%−270,314−12.0%ReducedHolders
Q3 20222,252,803$191.0M0.2%+87,163+4.0%AddedHolders
Q2 20222,165,640$179.5M0.2%+2,001,395+1,218.5%AddedHolders
Q1 2022164,245$12.7M<0.1%−34,114−17.2%ReducedHolders
Q4 2021198,359$17.5M<0.1%−10,771−5.2%ReducedHolders
Q3 2021209,130$16.2M<0.1%+15,055+7.8%AddedHolders
Q2 2021194,075$16.2M<0.1%+9,219+5.0%AddedHolders
Q1 2021184,856$14.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.